Fulgent Genetics (FLGT) Accumulated Expenses (2015 - 2026)

Fulgent Genetics has disclosed Accumulated Expenses across 12 years of filings, most recently posting $34.9 million for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $34.9 million, up 603.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.9 million (up 603.22% YoY), and the FY2025 annual result was $5.2 million, down 78.43% from the prior year.
• Accumulated Expenses came in at $34.9 million for Q1 2026 at Fulgent Genetics, up from $5.2 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $34.9 million in Q1 2026 to a low of $3.8 million in Q1 2024.
• The 5-year median for Accumulated Expenses is $21.7 million (2025), against an average of $18.1 million.
• Across the five-year window, Accumulated Expenses sank 82.15% in 2024 and surged 603.22% in 2026, its largest moves.
• Fulgent Genetics' Accumulated Expenses stood at $25.0 million in 2022, then slumped by 77.02% to $5.7 million in 2023, then soared by 322.91% to $24.3 million in 2024, then slumped by 78.43% to $5.2 million in 2025, then soared by 566.56% to $34.9 million in 2026.
• The last three Accumulated Expenses figures came in at $34.9 million (Q1 2026), $5.2 million (Q4 2025), and $23.0 million (Q3 2025), per Business Quant data.